Real-time financial, economic, and global news with market-focused context and analysis.
Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.
Bernstein SocGen Group lifted its price objective for Verizon Communications to $48 from $44 while retaining a Market Perform recommendation. The upgrade follows a robust fourth quarter in which Verizon posted sizable postpaid phone additions and renewed momentum in fixed wireless access net additions. Analysts and investors are parsing how the car…
InMode Ltd. (NASDAQ:INMD) shares rose modestly in Monday premarket trading after the company confirmed it has initiated a formal review of potential strategic alternatives. An independent directors committee has been formed and engaged outside legal and financial advisers to evaluate proposals, though the company cautioned there is no assurance the…
Allegro MicroSystems has shown accelerating revenue in industrial and automotive segments, producing strong free cash flow while market multiples remain rich but justifiable if growth persists. We outline a swing trade that leans on industrial demand and technical momentum with a clear entry, stop and target.
Shares of Northfield Bancorp Inc. (NFBK) climbed 11.9% in premarket trading after the announcement that Columbia Financial, Inc. (CLBK) will acquire Northfield in a transaction valued at about $597 million. The boards of both firms unanimously approved the merger, which will produce a pro forma regional bank with $18 billion in total assets as of D…
Trump Media and Technology Group Corp. (DJT) confirmed a February 2, 2026 record date for distribution of a proposed digital token program. Eligible recipients will be ultimate beneficial owners of at least one whole share as of that date, including shareholders registered with the company transfer agent. The company said tokens will be non-transfe…
Parex Resources (PARXF) has threaded a series of higher moving averages, a bullish MACD and a rising RSI while short interest remains extremely high. This trade idea targets a momentum-driven rally into the mid-$17s with a defined stop under the 50-day moving average. High short interest means volatility can work for or against you - position sizin…
Cantor Fitzgerald has reaffirmed an Overweight rating and a $350 price objective on Advanced Micro Devices (AMD), citing expectations for a slight beat in the December quarter and raised guidance for the March quarter. The firm points to robust Data Center demand across CPUs and GPUs, limited wafer-transition issues compared with Intel, and strateg…
Jefferies reduced its price target on Apogee Therapeutics Inc to $95 from $98 while keeping a Buy rating, citing investor reaction to developments around OX40 programs and related safety signals. The adjustment follows a roughly 6% drop in Apogee shares after Amgen ended an OX40 collaboration with Kyowa Kirin and Sanofi scaled back development of a…
Cantor Fitzgerald raised its price target on Qualcomm to $160 while retaining an Overweight rating, even as it forecasts weaker revenue across handset and QCT segments for calendar 2026. The research house expects solid December-quarter results but projects guidance for the March quarter modestly below consensus and June guidance well below consens…
Pharming Group NV shares dropped sharply in premarket trading after the U.S. Food and Drug Administration issued a Complete Response Letter for the supplemental New Drug Application for Joenja, citing concerns about possible underexposure in lower weight pediatric patients and problems with an analytical method used in production batch testing. The…
Bernstein analyst Gautam Chhugani argues that the recent Bitcoin sell-off may represent a rare long-term buying opportunity and possibly the final entry before Bitcoin's emergence as a sovereign asset. He points to a rapid institutional adoption via ETFs and corporate treasury purchases, notes Bitcoin's underperformance versus gold amid central ban…
Avalo Therapeutics (NASDAQ: AVTX) saw a 5.8% gain in premarket trading after Guggenheim initiated coverage with a Buy rating and a $50 price target. The firm's analyst cited the companys IL-1…
VerifyMe Inc. reported that it has satisfied Nasdaq’s minimum bid price requirement after its closing bid exceeded $1.00 for 10 consecutive business days from January 13 through January 29, 2026. The announcement came after a prior notification of non-compliance and preceded a 3.5% increase in premarket trading for the company’s shares.
Cantor Fitzgerald raised its price objective for Teradyne to $270 while keeping an Overweight rating, pointing to sustained revenue and earnings momentum tied to artificial intelligence-related businesses. The firm projects higher near-term and longer-term earnings per share, and expects company management to deliver optimistic guidance. Other anal…
France’s 2026 fiscal plan is set to pass as parliamentary no-confidence motions are expected to fail. The package seeks to narrow the deficit to 5% of GDP from an estimated 5.4% last year, after the government backed away from an earlier 4.7% target following concessions to the Socialist party. The plan combines extended levies on large firms, new …
Morgan Stanley says the release of Google’s Genie 3 world model has amplified concerns that generative world models could alter game production workflows. The bank highlights two potential trajectories for established game companies - integrating AI into existing engines or being overtaken by new technologies - and notes technical hurdles that favo…
Insmed shares have been knocked around by negative headlines on the development side, but the company already has a commercially approved DPP1 inhibitor, BRINSUPRI, with consensus peak sales potential near $5 billion. With a market cap of roughly $33.5 billion and supportive technicals, this trade idea buys the pullback into what we view as an othe…
A recent WarrenAI analysis spotlights three established companies that pair growth momentum with solid financial metrics. Cigna, First Solar and Newmont each show notable revenue expansion and analyst upside potential, while WarrenAI rates their financial health positively. These selections span healthcare, clean energy and precious metals, reflect…
Cantor Fitzgerald raised its price target on Regeneron Pharmaceuticals to $800 from $740 and kept an Overweight rating after updating near-term commercial portfolio estimates and applying modest values to several development programs. The firm highlighted obesity efforts, Dupixent lifecycle management and Factor XI research as drivers of higher val…
Scotiabank raised its 12-month price target for Verizon Communications to $50.25 from $48.00 while keeping a Sector Perform rating, citing the carrier's new churn-reduction plan and the inclusion of the Frontier acquisition in updated estimates. The bank says Verizon shares still look inexpensive, but it wants to see initial evidence that churn is …
Cantor Fitzgerald has maintained an Overweight rating on Definium Therapeutics Inc (NASDAQ:DFTX), while revising key inputs in its valuation model. The firm lowered its discount rate and adjusted penetration assumptions for two psychiatric indications, increasing its NPV estimate materially even as it trimmed EPS forecasts for 2025 and 2026. Other …
Greenland’s Prime Minister Jens-Frederik Nielsen told parliament that, despite U.S. President Donald Trump having ruled out the use of military force, Washington continues to pursue control and pathways to ownership of the Arctic island. Trump intensified calls earlier in the year for U.S. control citing national security concerns tied to Russia an…
Stephens raised its price objective on Ameris Bancorp to $87 from $79 while keeping an Equal Weight rating, citing stronger-than-expected core pre-provision net revenue (PPNR) and a firmer net interest margin (NIM). The new target implies roughly 8% upside from the stock's prevailing level and comes amid continued loan growth, elevated production, …
William Blair moved Palantir Technologies Inc. (PLTR) from Market Perform to Outperform on Monday, pointing to sustained momentum in both government and commercial channels. The upgrade, issued before Palantir’s upcoming earnings, notes strong tracker data, large partnership expansions, and enterprise adoption, even as the stock has experienced a s…
Stephens reduced its 12-month price target for Canadian National Railway (CNI) to $100 from $105 while retaining an Equal Weight rating. The move follows Q4 2025 results that beat estimates on adjusted EPS and operating ratio, but the firm cited flat revenue ton mile guidance, macroeconomic and trade-policy uncertainty, and rising expenses that lim…
